CD3ζ as a novel integration site for reprogramming immune cells with Chimeric Antigen Receptors

Опубликовано: 29 Август 2026
на канале: Labroots
174
3

Presented By: Dr. Dimitrios L. Wagner

Speaker Biography: Dr. Dimitrios Laurin Wagner is the head of Research and Development Unit at Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Germany...

Webinar: CD3ζ as a novel integration site for reprogramming immune cells with Chimeric Antigen Receptors

Webinar Abstract: Chimeric antigen receptor (CAR)-reprogrammed immune cells offer exciting therapeutic potential for addressing oncology, autoimmune diseases, transplant medicine, and infections. However, current approved CAR-T therapies rely on personalized manufacturing using viral gene transfer, resulting in challenges related to CAR-signaling regulation and limited accessibility due to the expensive personalized manufacturing...

Earn PACE Credits:
1. Make sure you’re a registered member of Labroots (https://www.labroots.com/ms/webinar/c...)
2. Watch the webinar on YouTube or on the Labroots Website (https://www.labroots.com/ms/webinar/c...)
3. Click Here to get your PACE credits (July 26, 2025): (https://www.labroots.com/credit/pace-...)

Labroots on Social:
Facebook:   / labrootsinc  
Twitter:   / labroots  
LinkedIn:   / labroots  
Instagram:   / labrootsinc  
Pinterest:   / labroots  
SnapChat: labroots_inc